Krystal Biotech to Participate in Cowen’s 42nd Annual Health Care Conference

Rhea-AI Summary

Krystal Biotech (NASDAQ: KRYS) announced that CEO Krish S. Krishnan will participate in a fireside chat at Cowen’s 42nd Annual Health Care Conference held virtually from March 7-9, 2022. The chat is scheduled for March 7, 2022, from 2:50 to 3:20 p.m. EST. Investors can access the webcast link here. Krystal Biotech specializes in redosable gene therapy, aiming to develop treatments for serious diseases, including rare skin and lung conditions. For further details, visit the official website.

News Market Reaction – KRYS

+5.26%

+5.26% Session move

In the trading session that priced this news, KRYS gained 5.26%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PITTSBURGH, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapy, today announced that Krish S. Krishnan, Chairman and Chief Executive Officer, will participate in a fireside chat at Cowen’s 42^nd Annual Health Care Conference, which is taking place virtually March 7-9, 2022.

Details are as follows:

Fireside Chat Date:	Monday, March 7, 2022
Fireside Chat Time:	2:50-3:20 p.m. EST
Webcast link:	https://wsw.com/webcast/cowen108/krys/2056797

A webcast of the presentation will be available for 90 days and can be found on the Krystal Biotech website at http://ir.krystalbio.com/events-and-presentations/events.

About Krystal Biotech
Krystal Biotech, Inc. (NASDAQ:KRYS) is a pivotal-stage gene therapy company leveraging its proprietary, redosable gene therapy platform and in-house manufacturing capabilities to potentially bring life-changing treatment options to patients with serious diseases, including rare diseases in skin, lung and other areas. For more information, please visit http://www.krystalbio.com and follow @KrystalBiotech on LinkedIn and Twitter.

CONTACTS:
Investors:
Whitney Ijem
Krystal Biotech
wijem@krystalbio.com

Media:
Tiffany Hamilton
Krystal Biotech
thamilton@krystalbio.com

FAQ

What is the date of the Krystal Biotech fireside chat?

The fireside chat for Krystal Biotech is scheduled for March 7, 2022.

What time will the fireside chat take place for Krystal Biotech?

The fireside chat will take place from 2:50 to 3:20 p.m. EST.

Where can I watch the Krystal Biotech fireside chat?

You can watch the Krystal Biotech fireside chat via the webcast link: https://wsw.com/webcast/cowen108/krys/2056797.

What type of company is Krystal Biotech?

Krystal Biotech is a pivotal-stage gene therapy company focused on developing treatments for serious diseases using redosable gene therapy.

Who is presenting at the Cowen Health Care Conference on behalf of Krystal Biotech?

Krish S. Krishnan, Chairman and CEO, will be presenting at the conference.